Uncategorized

Osteotech Expands Senior Management Team; New Executives to Drive Sales Force Strategies and Therapy-Based Solutions

EATONTOWN, N.J., Jan. 27 /PRNewswire/ — Osteotech, Inc. (Nasdaq: OSTE – News), a leader in the emerging field of biologic products for regenerative healing, announced today that it has appointed two experienced industry leaders to serve in the Company’s newly created roles of Senior Vice President of Sales and Senior Vice President of Tissue Engineering. These new positions underscore Osteotech’s commitment to executing its strategy to effectively bring to market innovative, therapy-driven products that meet the evolving needs of physicians and the patient communities.

Michael P. McCarthy has joined Osteotech as Senior Vice President of Sales and is responsible for further implementing and managing the Company’s sales model that incorporates distributor, channel partner and direct sales strategies. He most previously served as Chief Business Development Officer for Pipeline Biomedical Holdings, LLC, a medical products and technology development company. Robert C. Cohen has joined the Company as Senior Vice President of Tissue Engineering and will spearhead the Company’s efforts to fully translate Osteotech’s investments in technology-based therapies into innovative procedure-related products while also managing direct relationships with surgeon customers. He also joins Osteotech from Pipeline Biomedical, where he served as the Chief Technology Officer and oversaw technical new product due diligence, research and development, regulatory, clinical affairs and quality assurance. Messrs. McCarthy and Cohen will both report directly to Sam Owusu-Akyaw, Osteotech’s President and Chief Executive Officer.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button